The purpose of the Center for Medicinal Cannabis Research is to coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions.

news

 

California Highway Patrol Impaired Driving Task Force Meeting

Drs. Thomas Marcotte, Rob Fitzgerald, and Barth Wilsey attended the inaugural meeting of the California Highway Patrol Impaired Driving Task Force meeting on October 3, 2017. Pursuant to California Vehicle Code (CVC) Section 2429.7, the impaired driving task force will develop recommendations for best practices, protocols, proposed legislation, and other policies that will address the issue of impaired driving in California. The task force will also examine the use of technology, including field testing technologies and validated field sobriety tests, to identify drivers under the influence of prescription drugs, cannabis, and controlled substances.

Higher Education

Jim Benning, Westways, October, 2017

In the leafy Hillcrest neighborhood of San Diego, men and women are lighting joints, getting high, and then climbing behind the wheel. It’s just the kind of scenario that safety advocates feared when California voters approved the recreational use of marijuana last November. Except in this case, the wheel isn't connected to a car, but to a driving simulator.

These individuals are taking part in a three-year, statefunded $1.8 million study on the impact of marijuana on driving ability. Researchers at the University of California at San Diego’s Center for Medicinal Cannabis Research hope to answer a few key questions: Exactly how does marijuana affect a person’s ability to drive? How can officers most accurately measure levels of THC (marijuana’s active ingredient) in motorists and whether these drivers are impaired?

Read rest of the article


Hatch Introduces Medical Marijuana Research Bill

Press Release, September 13, 2017

Washington, D.C.– Today, Senator Orrin Hatch (R-UT) introduced the Marijuana Effective Drug Study Act of 2017, or MEDS Act, to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment. In introducing this legislation, Senator Hatch was joined by Senator Schatz (D-HI) and cosponsors Senator Chris Coons (D-DE), Senator Cory Gardner (R-CO), and Senator Thom Tillis (R-NC).

“It’s high time to address research into medical marijuana,” Hatch said. “Our country has experimented with a variety of state solutions without properly delving into the weeds on the effectiveness, safety, dosing, administration, and quality of medical marijuana. All the while, the federal government strains to enforce regulations that sometimes do more harm than good. To be blunt, we need to remove the administrative barriers preventing legitimate research into medical marijuana, which is why I’ve decided to roll out the MEDS Act.”

Read the full press release


Medical Marijuana and the Role of the Physician

Elizabeth Gardner, Anesthesiology News, July 12, 2017

Chicago—If an oncology practice hasn’t already started fielding inquiries from patients about medical marijuana, it’s probably only a matter of time, now that last November’s election has pushed the tally of medical marijuana states above 50%.

As availability grows, it’s important to understand the nuances of medical marijuana—what it will and won’t do, what forms are most effective for which uses, and how to determine whether it’s the best option for a given patient, said Judith Paice, PhD, RN, the director of the cancer pain program at Northwestern University’s Feinberg School of Medicine, in Chicago. Dr. Paice reviewed the current state of medical marijuana research at the 17th Lynn Sage Breast Cancer Symposium.

Read the rest of the article here...


More News

Click here to access the CMCR news archives.

Igor Grant, MD

UC San Diego Department of Psychiatry Grand Rounds: Medicinal Cannabis
(July 2017)




Igor Grant, MD

American Psychological Association Plenary Address: Marijuana as Medicine: Can we see past the smoke?
Denver, CO (August 2016)




Barth Wilsey, MD

Marijuana and Cannabinoids: A Neuroscience Research Summit;
Bethesda, MD (March 2016)



THE PSYCHIATRIC AND NEUROCOGNITIVE EFFECTS OF CANNABIS
(PDF)

Igor Grant, MD, FRCP(C) American Association for the Advancement of Science Annual Meeting

McGill University Health Centre - Research Institute
(February 2015)




Igor Grant, MD

41st Annual Summer Clinical Institute in Addiction Studies;
La Jolla, CA (June 2012)


Copyright © 2017 CENTER FOR MEDICINAL CANNABIS RESEARCH. | University of California, San Diego
cmcr@ucsd.edu | HNRP |